Literature DB >> 34480649

Predictors of aneurysm occlusion following treatment with the WEB device: systematic review and case series.

Fadi Al Saiegh1, Lohit Velagapudi1, Omaditya Khanna1, Ahmad Sweid1, Nikolaos Mouchtouris1, Michael P Baldassari1, Thana Theofanis1, Rizwan Tahir1, Victoria Schunemann1, Carrie Andrews1, Lucas Philipp1, Nohra Chalouhi2, Stavropoula I Tjoumakaris1, David Hasan3, M Reid Gooch1, Nabeel A Herial1, Robert H Rosenwasser1, Pascal Jabbour4.   

Abstract

The Woven EndoBridge (WEB) device is becoming increasingly popular for treatment of wide-neck aneurysms. As experience with this device grows, it is important to identify factors associated with occlusion following WEB treatment to guide decision making and screen patients at high risk for recurrence. The aim of this study was to identify factors associated with adequate aneurysm occlusion following WEB device treatment in the neurosurgical literature and in our case series. A systematic review of the present literature was conducted to identify studies related to the prediction of WEB device occlusion. In addition, a retrospective review of our institutional data for patients treated with the WEB device was performed. Demographics, aneurysm characteristics, procedural variables, and 6-month follow-up angiographic outcomes were recorded. Seven articles totaling 450 patients with 456 aneurysms fit our criteria. Factors in the literature associated with inadequate occlusion included larger size, increased neck width, partial intrasaccular thrombosis, irregular shape, and tobacco use. Our retrospective review identified 43 patients with 45 aneurysms. A total of 91.1% of our patients achieved adequate occlusion at a mean follow-up time of 7.32 months. Increasing degree of contrast stasis after WEB placement on the post-deployment angiogram was significantly associated with adequate occlusion on follow-up angiogram (p = 0.005) and with Raymond-Roy classification (p = 0.048), but not with retreatment (p = 0.617). In our systematic review and case series totaling 450 patients with 456 aneurysms, contrast stasis on post-deployment angiogram was identified as a predictor of adequate aneurysm occlusion, while morphological characteristics such as larger size and wide neck negatively impact occlusion.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aneurysm; Endovascular; Occlusion; WEB device

Mesh:

Year:  2021        PMID: 34480649     DOI: 10.1007/s10143-021-01638-7

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  28 in total

1.  Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: a single-center series with special emphasis on covered cortical branches and perforating arteries.

Authors:  Matthias Gawlitza; Anne-Christine Januel; Philippe Tall; Fabrice Bonneville; Christophe Cognard
Journal:  J Neurointerv Surg       Date:  2015-04-15       Impact factor: 5.836

2.  Predicting Factors of Angiographic Aneurysm Occlusion after Treatment with the Woven EndoBridge Device: A Single-Center Experience with Midterm Follow-Up.

Authors:  F Cagnazzo; R Ahmed; R Zannoni; C Dargazanli; P-H Lefevre; G Gascou; I Derraz; C Riquelme; A Bonafe; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2019-09-19       Impact factor: 3.825

3.  Placement of the Woven EndoBridge (WEB) device via distal transradial access in the anatomical snuffbox: A technical note.

Authors:  Fadi Al Saiegh; Nikolaos Mouchtouris; Ahmad Sweid; Nohra Chalouhi; Thana Theofanis; Ritam Ghosh; Stavropoula Tjoumakaris; M Reid Gooch; Robert H Rosenwasser; Pascal Jabbour
Journal:  J Clin Neurosci       Date:  2019-08-31       Impact factor: 1.961

4.  Remnants and recurrences after the use of the WEB intrasaccular device in large-neck bifurcation aneurysms.

Authors:  Christophe Cognard; Anne Christine Januel
Journal:  Neurosurgery       Date:  2015-05       Impact factor: 4.654

5.  Influence of smoking on aneurysm recurrence after endovascular treatment of cerebrovascular aneurysms.

Authors:  John Futchko; Jordan Starr; Darryl Lau; Matthew R Leach; Christopher Roark; Aditya S Pandey; B Gregory Thompson
Journal:  J Neurosurg       Date:  2017-06-23       Impact factor: 5.115

6.  Long-Term Outcomes of the WEB Device for Treatment of Wide-Neck Bifurcation Aneurysms.

Authors:  M Fujimoto; I Lylyk; C Bleise; P Albiña; J Chudyk; P Lylyk
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

7.  Procedural Clinical Complications, Case-Fatality Risks, and Risk Factors in Endovascular and Neurosurgical Treatment of Unruptured Intracranial Aneurysms: A Systematic Review and Meta-analysis.

Authors:  Annemijn M Algra; Antti Lindgren; Mervyn D I Vergouwen; Jacoba P Greving; Irene C van der Schaaf; Tristan P C van Doormaal; Gabriel J E Rinkel
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

Review 8.  Endovascular Treatment of Intracranial Aneurysms with the WEB Device: A Systematic Review of Clinical Outcomes.

Authors:  X Armoiry; F Turjman; D J Hartmann; R Sivan-Hoffmann; R Riva; P E Labeyrie; G Aulagner; B Gory
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-19       Impact factor: 3.825

9.  The safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide-necked bifurcation aneurysms: final 12-month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) Study.

Authors:  Adam S Arthur; Andy Molyneux; Alexander L Coon; Isil Saatci; Istvan Szikora; Feyyaz Baltacioglu; Ali Sultan; Daniel Hoit; Josser E Delgado Almandoz; Lucas Elijovich; Saru Cekirge; James V Byrne; David Fiorella
Journal:  J Neurointerv Surg       Date:  2019-04-16       Impact factor: 5.836

10.  Treatment of Acutely Ruptured Cerebral Aneurysms With the Woven EndoBridge Device: Experience Post-FDA Approval.

Authors:  Fadi Al Saiegh; David Hasan; Nikolaos Mouchtouris; Mario Zanaty; Ahmad Sweid; Omaditya Khanna; Nohra Chalouhi; Ritam Ghosh; Stavropoula Tjoumakaris; M Reid Gooch; Robert Rosenwasser; Pascal Jabbour
Journal:  Neurosurgery       Date:  2020-07-01       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.